DISAPPEARANCE RATE OF CONCENTRATED PROCONVERTIN EXTRACTS IN CONGENITAL AND ACQUIRED HYPOPROCONVERTINEMIA*
Open Access
- 1 March 1960
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 39 (3) , 554-563
- https://doi.org/10.1172/jci104068
Abstract
Extracts containing 35 to 88 times the proconvertin concentration of normal human plasma were produced by aluminum hydroxide adsorption of citrated plasma, elution with phosphate buffer and precipitation of the protein in the eluate at pH 5.6 with 40% ethanol at -5oC. Following 16 injections of these extracts into 9 human subjects, net increases in proconvertin of from 46% to 160% were achieved. In 1 normal subject a disappearance curve with a single exponential component having a half-time of 230 min. was found. In 1 2 mildly deficient and 1 moderately deficient congenital hypo-proconvertinemic patients disappearance curves with 2 exponential components were found. The half-time of the first component was 18 to 30 min. and that of the second was 210 to 240 min. In 4 severely deficient congenital hypoproconvertinemic patients, 1 patient with severe liver disease and 1 normal subject receiving oral Warfarin, disappearance curves with 2 exponential components were found. The half-time of the first component was 11 to 17 min. and that of the second 85 to 120 min. The average net increase in proconvertin at T = O was 104% of the predicted value in the severely''deficient patients and 159% in the normal, mild and moderately deficient patients. Intravenous administration of the extract on 5 occasions to 2 patients with congenital hypoproconvertinemia resulted in prompt cessation of gingival bleeding, epistaxis and rectal bleeding.Keywords
This publication has 10 references indexed in Scilit:
- Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man.1959
- [Congenital factor VII deficiency; family investigation and physiological studies on factor VII].1958
- Studies on the Turnover Rate of Stable Prothrombin Conversion Factor in ManActa Haematologica, 1958
- A Method for Assay of Stuart Factor.Experimental Biology and Medicine, 1957
- Stuart Clotting Defect. I. Segregation of an Hereditary Hemorrhagic State from the Heterogeneous Group Heretofore Called “Stable Factor” (SPCA, Proconvertin, Factor VII) DeficiencyJournal of Clinical Investigation, 1957
- The Effect of Dicumarol on the Transvascular Exchange of T-1824-Labeled Protein in RabbitsCirculation Research, 1956
- A simple, specific one-stage prothrombin assay using Russell's viper venom in cephalin suspension.1955
- [Purification of plasma thromboplastin factor B].1954
- CONGENITAL SPCA DEFICIENCY: A HITHERTO UNRECOGNIZED COAGULATION DEFECT WITH HEMORRHAGE RECTIFIED BY SERUM AND SERUM FRACTIONS 1Journal of Clinical Investigation, 1951
- The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and ProconvertinScandinavian Journal of Clinical and Laboratory Investigation, 1951